| Evaluation of Zinc Sulfate as an Adjunctive Therapy in COVID-19 Critically Ill Patients: a Two Center Propensity-score Matched Study RVGBK Khalid Al Sulaiman, Ohoud Aljuhani, Abdulrahman I. Al Shaya, Abdullah ... Critical Care 25 (363), 2021 | 35 | 2021 |
| Evaluation of inhaled nitric oxide (iNO) treatment for moderate-to-severe ARDS in critically ill patients with COVID-19: a multicenter cohort study K Al Sulaiman, GB Korayem, AF Altebainawi, S Al Harbi, A Alissa, ... Critical Care 26 (1), 304, 2022 | 24 | 2022 |
| Clinical pharmacy definition, required education, training and practice in Saudi Arabia: A position statement by the Saudi society of clinical pharmacy GB Korayem, HA Badreldin, K Eljaaly, A Aldemerdash, LK Al-Suhaibani, ... Saudi Pharmaceutical Journal 29 (11), 1343-1347, 2021 | 22 | 2021 |
| Recurrence of urinary tract infections and development of urinary-specific antibiogram for kidney transplant recipients GB Korayem, TT Zangeneh, KR Matthias Journal of global antimicrobial resistance 12, 119-123, 2018 | 18 | 2018 |
| Simulation-based education implementation in pharmacy curriculum: A review of the current status GB Korayem, OA Alshaya, SM Kurdi, LI Alnajjar, AF Badr, A Alfahed, ... Advances in medical education and practice, 649-660, 2022 | 17 | 2022 |
| Evaluation of Apixaban safety and effectiveness in morbidly obese patients with atrial fibrillation: a retrospective cohort study K Al Sulaiman, HA Badreldin, GB Korayem, AA Alenazi, F Alsuwayyid, ... Thrombosis Journal 20 (1), 25, 2022 | 12 | 2022 |
| The role of inhaled corticosteroids (ICS) in critically Ill patients with COVID-19: A multicenter, cohort study K Al Sulaiman, O Aljuhani, K Al Aamer, O Al Shaya, A Al Shaya, ... Journal of Intensive Care Medicine 37 (2), 248-257, 2022 | 12 | 2022 |
| Integrating simulation into advanced pharmacy practice experience curriculum: An innovative approach to training GB Korayem, AM Alboghdadly Saudi Pharmaceutical Journal 28 (7), 837-843, 2020 | 12 | 2020 |
| The clinical outcomes of COVID-19 critically ill patients co-infected with other respiratory viruses: a multicenter, cohort study K Al Sulaiman, O Aljuhani, HA Badreldin, GB Korayem, AA Alenazi, ... BMC infectious diseases 23 (1), 75, 2023 | 8 | 2023 |
| The prescribing pattern of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists in patient with type two diabetes mellitus: A two-center … GB Korayem, OA Alshaya, AA Alghamdi, SS Alanazi, MS Al Yami, ... Frontiers in Public Health 10, 1031306, 2022 | 8 | 2022 |
| The use of direct oral anticoagulants for thromboprophylaxis or treatment of cancer-associated venous thromboembolism: a meta-analysis and review of the guidelines GBKOAA Norah S. Alsubaie, Shahad M. Al Rammah, Reema A. Alshouimi, Mohammed ... Thrombosis Journal 19 (76), 2021 | 8 | 2021 |
| Association between tocilizumab and emerging multidrug‑resistant organisms in critically ill patients with COVID‑19: A multicenter, retrospective cohort study BMC infectious Disease 21 (1127), 2021 | 8 | 2021 |
| Evaluation of low-dose aspirin use among critically Ill patients with COVID-19: A multicenter propensity score matched study AF Al Harthi, O Aljuhani, GB Korayem, AF Altebainawi, RS Alenezi, ... Journal of Intensive Care Medicine 37 (9), 1238-1249, 2022 | 7 | 2022 |
| Comparison between standard Vs. Escalated dose venous thromboembolism (VTE) prophylaxis in critically ill patients with COVID-19: A two centers, observational study O Aljuhani, K Al Sulaiman, A Hafiz, K Eljaaly, A Alharbi, R Algarni, ... Saudi Pharmaceutical Journal 30 (4), 398-406, 2022 | 7 | 2022 |
| Single versus multiple doses of Tocilizumab in critically ill patients with coronavirus disease 2019 (COVID-19): A two-center, retrospective cohort study Journal of Critical Care 66, 44-51, 2021 | 7 | 2021 |
| Standard dosing of enoxaparin versus unfractionated heparin in critically ill patient with COVID-19: a multicenter propensity-score matched study K Al Sulaiman, O Aljuhani, GB Korayem, A Hafiz, M Alalawi, HA Badreldin, ... Thrombosis Journal 20 (1), 74, 2022 | 6 | 2022 |
| The safety and effectiveness of tocilizumab in older adult critically ill patients with COVID-19: a multicenter, cohort study GB Korayem, O Aljuhani, AF Altebainawi, AI Al Shaya, LI Alnajjar, A Alissa, ... International Journal of Infectious Diseases 122, 252-259, 2022 | 6 | 2022 |
| The impact of HMG-CoA reductase inhibitors use on the clinical outcomes in critically ill patients with COVID-19: A multicenter, cohort study K Al Sulaiman, O Aljuhani, GB Korayem, AF Altebainawi, S Al Harbi, ... Frontiers in Public Health 10, 877944, 2022 | 6 | 2022 |
| The correlation between non-O blood group type and recurrent catheter-associated urinary tract infections in critically ill patients: A retrospective study KA Sulaiman, N Al Qahtani, M Al Muqrin, M Al Dossari, A Al Wabel, ... Journal of International Medical Research 50 (7), 03000605221108082, 2022 | 6 | 2022 |
| Statins and risk of thrombosis in critically ill patients with COVID-19: a multicenter cohort study S Al Harbi, R Kensara, O Aljuhani, GB Korayem, AF Altebainawi, ... Clinical and Applied Thrombosis/Hemostasis 28, 10760296221103864, 2022 | 6 | 2022 |
